Position in SCLX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$156
+$23 QoQ
Shares Held
20
-37.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#38
of 72 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in SCLX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Operose Advisors LLC holds $4,264,256 across 12 Drug Manufacturers - General names. SCLX ranks #12 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
4,615 | $1,161,318 | |
| 2 | LLY |
ELI LILLY & Co
|
842 | $1,009,920 | |
| 3 | JNJ |
Johnson & Johnson
|
2,741 | $696,131 | |
| 4 | MRK |
Merck & Co., Inc.
|
4,872 | $626,052 | |
| 5 | PFE |
Pfizer Inc
|
25,400 | $611,632 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
800 | $101,072 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
500 | $28,810 | |
| 8 | AMGN |
Amgen Inc
|
73 | $26,434 |
All Filings in SCLX
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $156 | 20 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $133 | 20 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $243 | 20 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $393 | 20 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $117 | 20 | Shares | Sole | 2025-08-14 | |
| No filing history on record for this holder in this stock. | ||||||